WO2005066173A3 - Processes for the preparation of substituted azetidinone - Google Patents
Processes for the preparation of substituted azetidinone Download PDFInfo
- Publication number
- WO2005066173A3 WO2005066173A3 PCT/GB2005/000021 GB2005000021W WO2005066173A3 WO 2005066173 A3 WO2005066173 A3 WO 2005066173A3 GB 2005000021 W GB2005000021 W GB 2005000021W WO 2005066173 A3 WO2005066173 A3 WO 2005066173A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- processes
- preparation
- substituted azetidinone
- formula
- azetidinone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0400329.9A GB0400329D0 (en) | 2004-01-08 | 2004-01-08 | Novel processes |
GB0400329.9 | 2004-01-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005066173A2 WO2005066173A2 (en) | 2005-07-21 |
WO2005066173A3 true WO2005066173A3 (en) | 2008-12-31 |
Family
ID=31503577
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2005/000021 WO2005066173A2 (en) | 2004-01-08 | 2005-01-07 | Processes for the preparation of substituted azetidinone |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0400329D0 (en) |
WO (1) | WO2005066173A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017060418A1 (en) * | 2015-10-07 | 2017-04-13 | Neurovive Pharmaceutical Ab | Protected carboxylic acid-based metabolites for the treatment of mitochondria-related diseases |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995011905A1 (en) * | 1993-10-29 | 1995-05-04 | Smithkline Beecham Plc | 2-(pyrazol-3-yl)carbapenem derivatives |
WO1996034869A1 (en) * | 1995-05-03 | 1996-11-07 | Smithkline Beecham Plc | Esters of carbapenems |
-
2004
- 2004-01-08 GB GBGB0400329.9A patent/GB0400329D0/en not_active Ceased
-
2005
- 2005-01-07 WO PCT/GB2005/000021 patent/WO2005066173A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995011905A1 (en) * | 1993-10-29 | 1995-05-04 | Smithkline Beecham Plc | 2-(pyrazol-3-yl)carbapenem derivatives |
WO1996034869A1 (en) * | 1995-05-03 | 1996-11-07 | Smithkline Beecham Plc | Esters of carbapenems |
Also Published As
Publication number | Publication date |
---|---|
GB0400329D0 (en) | 2004-02-11 |
WO2005066173A2 (en) | 2005-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007001385A3 (en) | Process for preparing 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones | |
WO2007031858A3 (en) | An improved process for the preparation of beta-lactam antibiotic | |
EP1683785A4 (en) | Urea derivative and process for producing the same | |
WO2005105749A3 (en) | Process for making montelukast and intermediates therefor | |
ZA200604719B (en) | DPP-IV inhibitors | |
WO2006133147A3 (en) | Organic compounds | |
GB0719180D0 (en) | New process | |
WO2008079787A3 (en) | Glucokinase activators | |
WO2005082907A3 (en) | Pyrazolopyrimidines for controlling undesired microorganisms | |
TW200505919A (en) | DPP-IV inhibitors | |
WO2007053819A3 (en) | Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase iv and methods | |
JO2613B1 (en) | Organic Compounds | |
WO2005103037A3 (en) | Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments | |
MXPA06014139A (en) | Improved method for preparing 3-hydroxy-4-hydroxymethyl- pyrrolidine compounds. | |
IL174469A0 (en) | Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics | |
GB0412769D0 (en) | Organic compounds | |
WO2006021559A3 (en) | Method for producing tiotropium salts and silicon derivatives as intermediates | |
WO2004099197A3 (en) | Substituted oxyarenes, and use thereof for controlling pests | |
EP1666477A4 (en) | 7-(4-substituted 3- cyclopropylaminomethyl-1- pyrrolidinyl) q uinolonecarboxylic acid derivative | |
WO2007082262A3 (en) | Novel compounds | |
GB0411929D0 (en) | Organic compounds | |
WO2006036926A3 (en) | Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones | |
WO2007029084A3 (en) | A process for the preparation of carbapenem compounds | |
WO2008103367A3 (en) | Method for assembling high-purity chemical libraries, proapoptotic compounds discovered by same | |
WO2005066173A3 (en) | Processes for the preparation of substituted azetidinone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |